65862-106Level 3
Efavirenz (Efavirenz)
**Product type:** Human Prescription Drug
**Active ingredient:** EFAVIRENZ
**Strength:** 200 mg/1
**Dosage form:** Capsule
**Route:** Oral
**Labeler:** Aurobindo Pharma Limited
**Marketing category:** ANDA (ANDA078064)
**Pharmacologic class:** Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A Inducers [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Non-Nucleoside Analog [EXT], Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]
GET
/api/v1/systems/ndc_fda/nodes/65862-106Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.